Dual VEGF inhibition with sorafenib and bevacizumab (BEV) as salvage therapy in metastatic colorectal cancer (mCRC): results of the phase II North Central Cancer Treatment Group Study N054C
- Citation:
- J Clin Oncol vol 28 (15s) abstr 3549
- Meeting Instance:
- ASCO 2010
- Year:
- 2010
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3166
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- A. Grothey J. M. Lafky B. W. Morlan P. J. Stella S. R. Dakhil P. D. Steen W. S. Loui B. M. Bot S. R. Alberts J. T. Reynolds
- Networks:
- Study
- NCCTG-N054C
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: